Medical Design and Outsourcing Archives - Page 98 of 154

Former Zimmer Biomet executive has a new job

Carrie Nichol [Photo courtesy of Zimmer Biomet]

Carrie Nichol, the former chief accounting officer of Zimmer Biomet (NYSE:ZBH), has a new job outside of the medtech industry.

Nichol, who also served as vice president, controller and principal accounting officer at Zimmer Biomet, is now a VP and controller at Minnetonka, Minnesota-based Cargill.

Her departure was among the many notable medtech executive moves of 2021, and her destination wasn’t clear until recently.

Nichol left Zimmer Biomet in November after two years with the Warsaw, Indiana-based medical device company, which she joined in 2019 after serving as SVP, controller and chief accounting officer at pharma giant Endo International.

Zimmer Biomet did not name Nichol’s new employer when announcing her plans to leave, but a non-compete signed in 2019 meant she would likely exit the medtech industry (if the agreement is s…

Employees say Intuitive, Boston Scientific, J&J, Medtronic best places to work in 2022

Intuitive Surgical, Boston Scientific, Johnson & Johnson and Medtronic were recently named as Glassdoor’s employees’ choice of Best Places to Work in 2022.

Each year, Glassdoor uses feedback that employees have shared on the website over the past year to compile a list of the best places to work for the upcoming year. Employee reviews provide Glassdoor with insights into job and workplace attributes and qualitative feedback about why their employer provides the best place to work and what needs improvement.

Intuitive Surgical ranked 29 out of 100 on the Glassdoor list. The Sunnyvale, California-based company was listed at 41 for the previous year. It received a 4.4 out of 5 star rating over the last year. Some of its top reviews mention a “great work/life balance” with competitive salaries, benefits and stock options. The cons outlined suggest that Intuitive has a “very fast paced environment [with] high-performance expectation…

iRhythm CEO considers costs on the path to profitability

iRhythm’s Zio cardiac monitoring device [Image courtesy of iRhythm]

Fresh off positive reimbursement news for its Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind.

iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will need to keep costs under control as it grows to serve tens of millions and then hundreds of millions of patients in the years ahead.

“This means introducing things like automation where it’s possible, reconfiguring processes and streamlining systems and structures across the organization, as well as really rethinking how and where we do the work in this new remote environment that we’re proving can be so successful,” Blackford said today at the J.P. Morgan Healthcare Conference. “Ultimat…

Integer Holdings makes additions to its executive team

Integer Holdings today announced that it has appointed three new executives to its leadership team.

The appointments come as part of a planned transition due to retirements. Margaret Cathy is being promoted to senior VP of quality and regulatory affairs; Andrew Senn is being promoted to senior VP of strategy and business development and McAlister Marshall is was named senior VP and general counsel, chief ethics and compliance officer and corporate secretary.

Cathy replaces Joseph Flanagan who announced his retirement from the company in December. She previously served as the company’s VP of quality and regulatory and has been with the company since 2004. Prior to joining Integer, Cathy was a quality and regulatory leader for the European Region at Sola International, which is now Carl Zeiss.

Senn’s promotion follows the retirement announcement of Tony Borowicz, senior VP of strategy, business development and investor relations, who plans to r…

CES 2022: Medical technologies you need to know

Over 2,200 companies from around the world exhibited at this year’s CES. Nearly a fifth — 417 — were digital health companies.

Wearables continue to an important role at the event, which remains hybrid virtual and in-person amid the COVID-19 pandemic. There were 276 fitness and wearables exhibitors this year, 56 more than last year.

This year also marked an important first for the health tech space, with Abbott CEO Robert Ford presenting the first healthcare keynote at CES.

As the pandemic continues, so does the trend of devices to slow the spread of the virus. CES digital health exhibitors showcased technology that detects COVID, air purifiers, body temperature thermometers and more.

Here are 7 digital health and wearable products that stood out at this year’s show.

Next >>

FDA postpones some inspectional activities amid Omicron surge

[Photo by Martin Sanchez on Unsplash]

The FDA announced earlier this week that it made some temporary changes to its inspectional activities as a result of COVID-19.

With the Omicron variant of the virus causing surges across the world, the FDA implemented the changes in the U.S. on Dec. 29, 2021 to ensure the safety of its employees and the firms it regulates, according to a news release.

Through Jan. 19, 2022, the FDA plans to continue mission-critical work while postponing certain inspectional activities with the aim to restart those activities as soon as possible. Mission-critical foreign inspections will continue with plans reassessed as needed based on the monitoring of foreign travel conditions, the agency said.

FDA also confirmed it is postponing the planning of prioritized surveillance foreign inspection assignments that were scheduled to begin in February 2022. Mission-critical domestic …

Stryker CEO Lobo talks success of Wright Medical merger, increasing competitiveness of surgical robotics

Stryker CEO Kevin Lobo

CEO Kevin Lobo has a lot to be excited about at Stryker — the world’s largest orthopedic device company.

Kevin Lobo has seen many successful acquisitions at Stryker’s helm in the last 10 years. The Kalamazoo, Michigan medtech giant’s recent acquisition of Wright Medical has positioned the company to expand its orthopedics range – adding upper extremities to its vast portfolio of orthopedic devices and robotics.

Stryker announced the $4.7 billion acquisition of Wright Medical in November 2019 but didn’t fully acquire the company until November 2020 because of concerns raised by U.S. and U.K. regulators.

The company added Wright’s upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics devices to its portfolio. It then separated and re-organized its businesses into three separate business units within Str…

Abbott CEO touts future of biowearables in first-ever healthcare company keynote at CES

Eliud Kipchoge is training with Abbott’s Libre Sense to monitor his glucose levels to help him achieve optimal athletic performance.

Abbott (NYSE:ABT) Chairman & CEO Robert B. Ford highlighted what the future holds as he presented the first healthcare keynote ever at CES.

Speaking at the Consumer Electronics Show (CES) 2022 event, Ford headlined the “Human-Powered Health: Unlocking the Possibility of You” event, announcing that Abbott is developing a new category of biowearables called “Lingo.”

Get the full story at our sister site, MassDevice.

Ring Precision Components, New Vision Industries and Dieco combine into The Producto Group

Culper Capital Partners announced that it acquired Ring Precision Components, New Vision Industries and Dieco.

As a result of the acquisition of the Ring Precision, New Vision and Dieco, Culper has formed its first control platform, the Producto Group, according to a news release. Ring Precision and Dieco were sold as part of a corporate carveout from The PMT Group, while New Vision was acquired from its majority shareholder, Culper said.

Through Ring Precision and New Vision, the Producto Group will serve as a contract manufacturer and a provider of precision tooling and components for a wide variety of industries, including the medical, semiconductor, aerospace, and defense markets. Dieco will serve as the company’s distribution arm, providing custom springs, die springs, accessories, die sets and other components.

“We are excited to complete the acquisition of three great businesses to form the Producto Group,” Culper Managing Partne…

How Abbott seeks to improve care, health inequities for people with cardiovascular disease

[Image courtesy of Abbott]

Abbott is on a mission to grasp the scope of the patient journey through cardiovascular disease diagnosis and treatment.

The company’s Beyond Intervention Initiative kicked off a few years ago to improve patient care and quality of life. What Abbott found was that there is plenty of ground to make up.

“That’s what all these life-changing technologies that we developed are about,” CMO & Divisional VP of Medical Affairs for Abbott’s Vascular Business Dr. Nick West told Medical Design & Outsourcing. “If we’re not going to improve the quality of life and, indeed, the number of patients, the amount of life and improve patient care, then what are we doing?”

Year one data from the initiative — with feedback from more than 1,800 patients with cardiovascular disease, physicians and healthcare leaders — highlighted disruption wi…

VitalPath acquires Modern Catheter Technologies

VitalPath announced today that it acquired catheter delivery system developer Modern Catheter Technologies.

The Roseville, Minnesota-based company said in a news release that the acquisition builds upon its acquisition of VitalDyne in March 2021.

Maplewood, Minnesota-based ModernCath’s microcatheter expertise brings added strength to VitalPath’s services in the neurovascular, coronary and peripheral market segments, the company said.

“ModernCath is a strategic addition to expand and scale the VitalPath platform,” VitalPath CEO Randall Sword said in the release. “ModernCath’s strength in the neurovascular and electrophysiology markets complements VitalPath’s expertise in the structural heart and peripheral markets. And their exceptional extrusion capabilities will be a valuable addition to our strength in laser processing technologies and finished device manufacturing.”

VitalPath said the acquisition will expand its ability to scale, i…

MedAcuity appoints new COO, VP of engineering

MedAcuity announced today that it appointed Karl Pessinis as its COO and promoted Tony Carter to VP of engineering.

Pessinis joins Westford, Massachusetts-based MedAcuity having most recently served as managing director at All Covered (Konica Minolta Technology Services), responsible for New England.

His experience ranges across other technology services leadership roles as he has also provided management consulting to companies similar to MedAcuity, according to a news release.

Carter joined MedAcuity in 2017 as a program manager and eventually moved up to director of engineering, MedAcuity said. His new role as VP of engineering hands him the responsibility of overseeing the company’s software and quality engineering teams.

MedAcuity said Carter has prioritized establishing a comprehensive learning and development culture to support the education of the company’s technical staff.

“After 14 successful years of business, we are …